| Exclusive: U.S. health regulator Verma eyes new methods for drug pricing | | | NEW YORK (Reuters) - The U.S. government is considering setting new payment methods aimed at curbing costs for Medicare and Medicaid coverage of breakthrough medical treatments with very high prices, particularly novel gene-based therapies for cancer and other diseases, a top health official said on Thursday. |
| |
| Indivior drug to fight opioid addiction approved by U.S. FDA | | | (Reuters) - Indivior's experimental drug to help fight America's growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product. |
| |
| FDA clears first medical device accessory for Apple Watch | | | (Reuters) - The U.S. Food and Drug Administration on Thursday cleared a device embedded in an Apple Inc watch band that monitors a user's heart rate, detects when something is amiss and prompts the user to take an electrocardiogram. |
| |
| Foundation's cancer gene test gets U.S. FDA and Medicare nod | | | CHICAGO (Reuters) - A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said. |
| |
| Marriage linked to lower dementia risk | | | (Reuters Health) - Being married, or ever having been married, comes with a much lower risk of developing dementia compared to being a lifelong bachelor or bachelorette, a new analysis of previous studies suggests. |
| |
| | |
